Back to Search
Start Over
JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis.
- Source :
- Leukemia (08876924); Aug2014, Vol. 28 Issue 8, p1736-1738, 3p
- Publication Year :
- 2014
-
Abstract
- A letter to the editor is presented concerning ruxolitinib and Janus kinase (JAK) inhibition as pretreatment for allogeneic stem cell transplantation (ASCT).
- Subjects :
- STEM cell transplantation
DRUG therapy
Subjects
Details
- Language :
- English
- ISSN :
- 08876924
- Volume :
- 28
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Leukemia (08876924)
- Publication Type :
- Academic Journal
- Accession number :
- 97362679
- Full Text :
- https://doi.org/10.1038/leu.2014.86